fluorodeoxyglucose f18 has been researched along with Androgenization in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Andreou, J; Efthimiadou, R; Gogou, L; Laspas, F; Prassopoulos, V; Vlachou, F | 1 |
| Avram, AM; Fig, LM; Gross, MD | 1 |
1 review(s) available for fluorodeoxyglucose f18 and Androgenization
| Article | Year |
|---|---|
Adrenal gland scintigraphy.
Topics: 3-Iodobenzylguanidine; Adrenal Gland Diseases; Adrenal Gland Neoplasms; Adrenal Glands; Cushing Syndrome; Female; Fluorodeoxyglucose F18; Humans; Hyperaldosteronism; Incidental Findings; Iodine Radioisotopes; Magnetic Resonance Imaging; Male; Paraganglioma; Pheochromocytoma; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, Emission-Computed, Single-Photon; Tomography, X-Ray Computed; Ultrasonography; Virilism | 2006 |
1 other study(ies) available for fluorodeoxyglucose f18 and Androgenization
| Article | Year |
|---|---|
Leydig cell tumour of the ovary localised with positron emission tomography/computed tomography.
Topics: Adult; Female; Fluorodeoxyglucose F18; Humans; Leydig Cell Tumor; Multimodal Imaging; Ovarian Neoplasms; Ovariectomy; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, X-Ray Computed; Treatment Outcome; Tumor Burden; Virilism | 2011 |